publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
background
respiratori
viral
infect
known
clinic
promot
sensit
antigen
inhal
develop
asthma
object
purpos
investig
determin
whether
influenza
type
viru
infect
enhanc
inhal
sensit
increas
airway
respons
mice
clinic
asthma
exacerb
respiratori
viral
infect
older
children
adult
rhinoviru
coronaviru
influenza
viru
infect
caus
wheez
airway
hyperrespons
develop
subject
natur
acquir
cold
infect
respiratori
virus
transient
acut
respiratori
infect
also
implic
pathogenesi
asthma
known
children
respiratori
viru
infect
later
experi
wheez
airway
hyperrespons
asthma
epidemiolog
studi
respiratori
infect
asthma
allerg
rhiniti
area
smith
found
viral
lowerrespiratori
infect
earli
life
trigger
onset
asthma
although
still
unknown
viral
infect
induc
asthma
respiratori
viral
infect
may
contribut
develop
ige
antibodi
environment
antigen
influenza
caus
exfoli
epitheli
cell
increas
permeabl
respiratori
mucos
barrier
antigen
penetr
enhanc
likelihood
ige
antibodi
sensit
respiratori
viru
infect
propos
common
trigger
factor
develop
allergi
genet
suscept
children
sever
studi
sensit
allergen
inhal
alon
report
repeat
exposur
allergen
high
concentr
need
sakamoto
et
al
shown
ige
antibodi
product
respons
inhal
antigen
occur
mice
infect
influenza
viru
anim
infect
thu
hypothes
respiratori
viral
infect
promot
sensit
inhal
antigen
may
caus
asthma
test
hypothesi
mice
infect
influenza
type
viru
acut
phase
anim
expos
aerosol
ovalbumin
two
week
ovalbumin
sensit
mice
challeng
ovalbumin
aerosol
hour
challeng
airway
respons
methacholin
level
ovalbuminspecif
ige
bronchoalveolar
lavag
fluid
examin
use
strain
influenza
virus
h
n
aguizhoux
h
n
examin
differ
effect
strain
influenza
virus
allerg
sensit
sixto
male
balbc
mice
japan
slc
shizuoka
japan
use
anim
maintain
ovalbuminfre
diet
kept
special
pathogenfre
condit
laminar
flow
contain
group
anim
isol
experiment
anim
use
studi
maintain
protocol
approv
institut
anim
care
use
committe
yokohama
citi
univers
school
medicin
ovalbumin
sigma
chemic
st
loui
mo
dissolv
pb
concentr
ten
millilit
alum
adjuv
mgml
ad
ml
ovalbumin
final
concentr
ovalbumin
aerosol
ovalbumin
use
sensit
challeng
mice
sensit
inhal
aerosol
ovalbumin
pb
ultrason
nebul
omron
tokyo
japan
aerosol
ovalbumin
pb
expos
anim
plexiglass
chamber
capac
l
minut
day
period
inhal
challeng
aerosol
ovalbumin
pb
ultrason
nebul
minut
two
mouseadapt
strain
influenza
h
n
aguizhoux
h
n
provid
dr
tashiro
tamura
japan
nation
institut
health
respect
use
present
studi
virus
incub
madindarbi
canin
kidney
cell
monolay
day
virus
harvest
viru
titer
quantit
plaqu
assay
describ
previous
titer
pool
use
present
studi
plaqueform
unit
pfu
h
n
pfu
h
n
anim
anesthet
diethylen
ether
inocul
intranas
l
dilut
viru
solut
viru
stock
solut
dilut
pb
nonspecif
airway
respons
measur
inhal
methacholin
aerosol
unanesthet
spontan
breath
anim
specif
airway
resist
sraw
measur
doubl
plethysmograph
apparatu
consist
head
chamber
chest
chamber
small
anim
buxco
troy
ny
accord
method
pennock
et
al
briefli
pressur
signal
head
chest
chamber
repres
nasal
flow
thorac
flow
respect
signal
display
oscilloscop
use
calcul
total
respiratori
durat
time
lag
nasal
flow
sraw
calcul
accord
follow
formula
angular
speed
p
b
atmospher
pressur
millimet
mercuri
phase
angl
head
bodi
chamber
warm
measur
air
head
chamber
satur
water
vapor
pool
heat
water
insid
box
neck
anim
place
bore
rubber
plate
separ
chamber
seal
tightli
clay
avoid
air
leak
chamber
measur
sraw
perform
anim
quiet
examin
whether
sraw
doubl
plethysmograph
repres
chang
airway
resist
lower
airway
anesthet
anim
intraperiton
inject
pentobarbit
sodium
mganim
insert
long
steril
plastic
tube
trachea
tube
connect
head
chamber
bodi
plethysmograph
abl
measur
sraw
lower
airway
sraw
l
sraw
sraw
l
measur
aerosol
inhal
either
pb
methacholin
mgml
compar
sraw
sraw
l
nonsensit
noninfect
anim
concentr
methacholin
adjust
mgml
serial
dilut
pb
aerosol
devilbiss
nebul
de
vilbiss
somerset
pa
deliv
anim
mask
put
face
anim
place
chest
chamber
head
chamber
disconnect
anim
expos
aerosol
minut
concentr
head
chamber
connect
sraw
measur
inhal
methacholin
start
concentr
gml
concentr
increas
sraw
increas
baselin
valu
methacholinesraw
curv
calcul
cumul
dose
sum
inhal
dose
pd
mch
sraw
increas
baselin
valu
inhal
pb
aerosol
one
unit
defin
dose
inhal
mgml
methacholin
minut
anim
sraw
increas
concentr
mgml
dose
unit
sum
pd
mch
calcul
unit
immedi
assess
airway
respons
anim
anesthet
pentobarbit
sodium
mgkg
pb
ml
instil
tracheal
cannula
recov
gentl
manual
aspir
lavag
repeat
time
recov
fluid
immedi
centrifug
minut
cell
pellet
wash
twice
resuspend
ml
pb
cell
fix
slide
cytocentrifug
cytobucket
tomi
seiki
tokyo
japan
stain
diffquick
intern
reagent
kobe
japan
differenti
cell
count
perform
classif
accord
standard
morpholog
criteria
least
cell
lymphocyt
bal
fluid
balf
analyz
total
number
lymphocyt
express
lymphoid
surfac
marker
antimous
monoclon
antibodi
specif
pharmingen
san
diego
calif
previous
describ
cell
fix
slide
air
dri
immers
aceton
solut
cool
minut
store
cell
slide
incub
minut
h
methanol
wash
distil
water
pb
minut
incub
primari
antiserum
dilut
pb
done
minut
wash
pb
minut
cell
slide
incub
dilut
biotinyl
secondari
antibodi
solut
minut
cell
treat
avidinperoxidas
complex
vectastain
elit
abc
kit
vector
laboratori
burlingam
calif
peroxidas
activ
demonstr
incub
diaminobenzidin
count
cell
posit
end
experi
blood
drawn
postorbit
vein
heart
anim
measur
ovalbuminspecif
ige
respect
ovalbuminspecif
ige
antibodi
level
measur
elisa
follow
elisa
plate
immunolon
ii
dynatech
laboratori
alexandria
va
coat
gml
ovalbumin
plate
block
bsa
dilut
sampl
incub
plate
hour
plate
wash
overlaid
gml
alkalin
phosphataseconjug
polyclon
antimous
ige
pharmingen
hour
wash
plate
read
micropl
autoread
biorad
laboratori
hercul
calif
concentr
specif
antibodi
bound
plate
determin
comparison
standard
curv
gener
use
hightit
antisera
ovalbumin
lung
fix
intratrach
instil
buffer
formaldehyd
solut
lung
section
embed
paraffin
section
stain
hematoxylin
eosin
dose
effect
virus
determin
dose
virus
h
n
h
n
requir
caus
moder
inflamm
without
appar
pneumonia
inocul
intranas
l
dilut
viru
solut
infect
verifi
observ
pulmonari
histolog
day
inocul
gener
locomotor
activ
bodi
weight
surviv
rate
examin
day
five
anim
use
group
examin
effect
influenza
viru
infect
inhal
sensit
ovalbumin
divid
anim
group
anim
group
group
pb
inocul
pb
sensit
pb
challeng
group
pb
inocul
ovalbumin
sensit
ovalbumin
challeng
group
h
n
inocul
pb
sensit
pb
challeng
group
h
n
inocul
pb
sensit
pb
challeng
group
h
n
inocul
ovalbumin
sensit
ovalbumin
challeng
group
h
n
inocul
ovalbumin
sensit
ovalbumin
challeng
dose
effect
studi
subleth
dosag
determin
pfuml
pfuml
h
n
h
n
respect
first
measur
pd
mch
drew
blood
postorbit
vein
determin
ige
day
inocul
viru
pb
perform
intranas
day
anim
sensit
ovalbumin
pb
minut
daili
day
mice
challeng
aerosol
ovalbumin
pb
minut
twentyfour
hour
challeng
airway
respons
level
ovalbuminspecif
ige
balf
analyz
lung
remov
fix
valu
express
mean
sem
statist
comparison
group
examin
analysi
varianc
repeat
measur
anova
follow
posthoc
comparison
newmankeul
test
two
mean
valu
compar
wilcoxon
match
pair
test
p
valu
less
consid
signific
bodi
weight
anim
inocul
h
n
dilut
decreas
time
howev
dilut
weight
increas
fig
h
n
strain
bodi
weight
decreas
time
dilut
dilut
weight
increas
inocul
h
n
viru
dilut
anim
die
day
day
histolog
evid
show
appar
pneumonia
dilut
h
n
viru
anim
die
anim
pneumonia
anim
inocul
dilut
h
n
viru
show
mononuclearcel
infiltr
submucos
layer
perivascular
area
loss
epithelium
airway
day
fig
b
littl
inflamm
observ
day
dilut
appar
inflamm
observ
anim
die
dilut
h
n
viru
dilut
h
n
viru
mononuclear
cell
infiltr
signific
anim
show
pneumonia
dilut
loss
airway
epitheli
cell
mononuclear
cell
infiltr
without
pneumonia
observ
fig
c
anim
inocul
dilut
h
n
viru
show
littl
mononuclear
cell
infiltr
sensit
studi
chose
dilut
h
n
h
n
ie
pfuml
respect
inflammatori
chang
observ
control
fig
comparison
sraw
sraw
l
individu
mice
indic
close
correl
r
p
although
absolut
valu
sraw
l
tend
lower
sraw
high
level
airway
resist
fig
mean
sraw
reflect
approxim
respons
lower
airway
resist
differ
baselin
sraw
inhal
methacholin
observ
either
inocul
hour
challeng
among
group
threshold
valu
inhal
methacholin
pd
mch
measur
hour
challeng
decreas
anim
sensit
ovalbumin
inocul
either
h
n
group
h
n
group
compar
respect
baselin
valu
p
fig
decreas
pd
mch
differ
h
n
h
n
group
howev
neither
ovalbumin
sensit
alon
group
viru
infect
alon
group
chang
airway
respons
level
ovalbuminspecif
ige
increas
arbitrari
unit
ovalbumin
sensit
inocul
h
n
group
p
ovalbumin
sensit
inocul
h
n
compar
baselin
valu
group
p
fig
howev
chang
level
ovalbuminspecif
ige
occur
anim
inocul
pb
ovalbumin
challeng
group
total
balf
cell
number
ovalbumin
sensit
h
n
inocul
group
higher
group
howev
group
increas
tabl
percent
alveolar
macrophag
decreas
group
h
n
viru
infect
alon
p
group
ovalbumin
sensit
viru
infect
p
group
fig
lymphocyt
balf
increas
group
h
n
viru
infect
alon
p
group
ovalbumin
sensit
viru
infect
group
compar
group
pb
inocul
ovalbumin
sensit
p
group
p
group
group
pb
inocul
pb
sensit
p
increas
lymphocyt
greater
h
n
ovalbumin
sensit
group
h
n
alon
group
p
howev
h
n
viru
infect
alon
increas
percent
lymphocyt
chang
observ
either
percent
neutrophil
percent
eosinophil
studi
tcell
popul
balf
balf
cell
h
n
inocul
group
immunostain
total
cell
h
n
inocul
alon
group
h
n
ovalbumin
sensit
group
respect
significantli
higher
pb
inocul
group
group
p
fig
number
cell
chang
viru
infect
andor
ovalbumin
sensit
howev
viru
infect
either
pb
ovalbumin
sensit
increas
cell
balf
p
increas
ovalbumin
sensit
viru
infect
significantli
greater
pb
sensiti
histolog
examin
lung
perform
hour
ovalbumin
pb
challeng
day
anim
inocul
either
h
n
h
n
viru
follow
pb
sensit
inflammatori
cell
infiltr
found
fig
howev
virusinocul
anim
ovalbumin
sensit
group
mononuclearcel
infiltr
observ
around
bronchioli
blood
vessel
fig
b
c
differ
inflamm
observ
group
eosinophil
infiltr
detect
group
demonstr
infect
influenza
virus
enhanc
inhal
sensit
ovalbumin
airway
respons
methacholin
mice
differ
airway
respons
ovalbuminspecif
ige
cell
balf
observ
strain
influenza
viru
h
n
h
n
first
report
mice
influenza
viru
infect
boost
sensit
inhal
lowconcentr
antigen
increas
airway
respons
although
anim
asthma
model
subcutan
intraperiton
inject
common
rout
antigen
immun
inhal
sensit
techniqu
may
reflect
appropri
actual
rout
sensit
develop
human
asthma
studi
suggest
viral
infect
import
trigger
sensit
aeroallergen
onset
asthma
influenza
virus
import
respiratori
virus
respect
morbid
mortal
rate
world
use
strain
influenza
viru
h
n
h
n
examin
differ
viru
strain
effect
allergen
sensit
present
studi
highest
dose
influenza
virus
caus
pneumonia
anim
die
moder
dose
virus
use
allergen
sensit
studi
anim
surviv
without
pneumonia
show
infiltr
mononuclear
cell
airway
wall
perivascular
area
day
inocul
although
present
studi
virul
virus
stronger
strain
h
n
h
n
dose
strain
use
sensit
caus
compar
chang
histolog
condit
chang
similar
previou
studi
sensit
ovalbumin
perform
acut
phase
infect
day
viru
inocul
thu
viru
infect
damag
airway
epithelium
chang
epitheli
permeabl
may
facilit
access
allergen
lumen
airway
wall
inflamm
lung
tissu
influenza
virus
reach
maximum
day
almost
recov
day
viru
inocul
bal
perform
day
viru
inocul
total
cell
number
group
viru
infect
alon
differ
group
inocul
pb
increas
cell
number
lung
acut
phase
influenza
viru
infect
declin
normal
valu
week
inocul
percent
lymphocyt
increas
anim
viru
infec
tion
circul
lymphocyt
report
decreas
acut
phase
infect
decreas
persist
week
viru
inocul
lymphocyt
may
accumul
lung
viru
infect
associ
decreas
circul
analysi
lymphocyt
subset
tcell
popul
found
increas
viru
infect
alon
group
tcell
subset
viru
infect
alon
group
cell
increas
cell
although
chang
either
cell
observ
group
inocul
pb
group
ratio
balf
lymphocyt
decreas
influenza
viru
infect
primarili
increas
cell
chang
tcell
subset
similar
previou
studi
viru
infect
convalesc
respiratori
syncyti
viru
infect
circul
tcell
number
lower
patient
wheez
without
wheez
howev
differ
cell
seen
suggest
cell
may
accumul
lung
patient
wheez
allergen
sensit
consid
control
cell
anim
model
inhal
sensit
ovalbumin
tcell
subset
spleen
report
chang
cell
increas
ratio
decreas
sensit
induct
immun
respons
ovalbumin
switch
virusinfect
tcell
respons
product
thu
allergen
sensit
viru
infect
cell
increas
lung
like
allergen
sensit
viru
infect
control
directli
cell
cytokin
produc
cell
eosinophil
group
ovalbumin
sensit
viru
infect
increas
lung
tissu
balf
balbc
mous
model
sensit
repeat
exposur
ovalbumin
eosinophil
observ
airway
wherea
ige
level
increas
sensit
intraperiton
inject
alon
mice
increas
eosinophil
either
lung
tissu
balf
eosinophil
peroxidas
activ
chang
ovalbumin
challeng
although
increas
airway
respons
observ
thu
term
eosinophil
result
compar
studi
mous
model
asthma
balbc
mice
allergen
inhal
seldom
induc
eosinophilia
ige
product
report
increas
mous
model
asthma
sensit
ovalbumin
inhal
alon
caus
signific
product
ige
inhal
ovalbumin
influenza
infect
produc
high
level
ovalbuminspecif
ige
differ
ige
product
h
n
h
n
strain
sakamoto
et
al
show
ovalbumin
inhal
influenza
viru
infect
gener
ovalbuminspecif
ige
measur
pca
therefor
influenza
infect
amplifi
ige
product
exposur
aerosol
lowconcentr
allergen
alon
produc
ige
prospect
studi
allerg
symptom
immunolog
evid
ige
rast
specif
allergen
develop
children
parent
allergi
upper
respiratori
infect
occur
children
month
onset
allerg
sensit
viru
infect
enhanc
product
specif
ige
allergen
inhal
respiratori
syncyti
virusinfect
mice
develop
high
ovalbuminspecif
ige
respons
intranas
sensit
ovalbumin
howev
uninfect
anim
suggest
respiratori
viru
infect
may
chang
immun
respons
antigen
rat
alveolar
macrophag
elimin
ige
product
increas
respons
inhal
allergen
resid
alveolar
macrophag
report
downregul
antigen
cell
function
pulmonari
dendrit
cell
balf
analysi
show
infect
influenza
virus
increas
lymphocyt
decreas
number
alveolar
macrophag
like
viru
infect
enhanc
antigen
cell
function
result
increas
ige
product
cell
influenza
virusinfect
mice
coexpress
differ
combin
cytokin
also
report
virusspecif
cell
lung
switch
product
upregul
ige
synthesi
lung
influenza
virusinfect
mice
express
mrna
granulocytemacrophag
colonystimul
factor
thu
influenza
viru
infect
may
caus
cellpopul
chang
lung
tissu
function
chang
cell
cytokin
product
restrict
tcell
popul
result
increas
ige
product
mice
measur
airway
function
feasibl
measur
sraw
unanesthet
anim
anesthesia
affect
airway
respons
howev
question
airway
resist
measur
use
whole
bodi
plethysmographi
anim
breath
nose
sraw
domin
upper
airway
resist
recent
hamelmann
et
al
demonstr
index
airway
resist
penh
bodi
plethysmographi
includ
upper
lower
airway
valid
indic
bronchoconstrict
inhal
challeng
nose
confirm
sraw
reflect
chang
lower
airway
resist
fig
howev
absolut
valu
airway
resist
calcul
assum
function
residu
capac
frc
ml
approxim
cm
h
oml
baselin
higher
previous
report
valu
resist
measur
mechan
ventil
anesthesia
induc
method
resist
measur
differ
ventil
frequenc
magnitud
tidal
ventil
determin
set
ventil
frc
adjust
control
endexpiratori
pressur
mice
breath
air
spontan
thu
differ
method
resist
measur
frc
ventil
frequenc
tidal
volum
may
affect
absolut
valu
resist
studi
may
need
determin
precis
valu
airway
resist
mice
balbc
mice
airway
respons
ige
product
increas
anim
sensit
inhal
ovalbumin
alon
use
ovalbumin
inhal
sensit
thought
lower
concentr
inhal
allergen
may
caus
weaker
allerg
respons
howev
inhal
sensit
ovalbumin
pb
inocul
increas
neither
airway
respons
ige
product
lack
allerg
respons
may
due
low
concentr
inhal
allergen
ovalbumin
sensit
group
influenzaviru
infect
airway
respons
increas
although
neither
viru
infect
alon
ovalbumin
sensit
alon
affect
airway
respons
measur
day
inocul
virus
balcel
number
increas
inflammatori
chang
recov
histolog
model
airway
inflamm
may
caus
increas
airway
respons
mechan
airway
diamet
may
relat
airway
respons
baselin
airway
resist
differ
among
experiment
group
therefor
increas
airway
respons
may
due
airway
obstruct
inflamm
eosinophil
airway
import
caus
increas
airway
respons
relationship
eosinophil
number
balf
airway
respons
shown
mild
asthma
anim
increas
airway
respons
report
associ
eosinophil
infiltr
lung
tissu
balf
howev
eosinophil
found
ovalbumin
sensit
viru
infect
asthma
model
mice
airway
respons
associ
eosinophilia
lung
tissu
balf
reflect
result
suggest
increas
airway
respons
may
develop
mean
mechan
independ
eosinophil
inflamm
cell
ovalbuminsensit
anim
transfer
naiv
anim
increas
airway
respons
induc
transfer
anim
cell
particularli
cell
increas
group
ovalbumin
sensit
viru
infect
recent
report
ovalbuminsensit
anim
deplet
cell
develop
airway
hyperrespons
although
anim
ovalbumin
sensit
alon
airway
hyperrespons
transfer
cell
restor
airway
hyperrespons
virusspecif
cell
challeng
differ
antigen
type
immun
respons
involv
product
eosinophilia
occur
airway
describ
earlier
virusinfect
cell
may
enhanc
ige
product
induct
allergenspecif
ige
product
believ
element
contribut
increas
airway
respons
variou
anim
model
asthma
airway
respons
increas
increas
ige
level
regard
data
compar
previou
studi
therefor
increas
igeand
type
immun
respons
cell
may
contribut
increas
airway
respons
